Manufacturing AbbVie opts for North Carolina to house $1.4bn manufacturing site Pharmaceutical TechnologyThis Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.ManufacturingRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) Pharmaceutical Technology This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production. ManufacturingRead full story Post navigation Previous: MSD teams up with Google Cloud on agentic AI transformationNext: Sanofi receives FDA approval for Tzield in paediatric diabetes Related Stories Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
